Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2000)
Onko-PET der Deutschen Gesellschaft fur Nuklearmedizin. Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors
D. Hellwig, D. Ukena, F. Paulsen, M. Bamberg, C. Kirsch, Onko-PET Nuklearmedizin (2001)
[Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000].Pneumologie, 55 8
P. Goldstraw, J. Crowley, K. Chansky, D. Giroux, P. Groome, R. Rami-Porta, P. Postmus, V. Rusch, L. Sobin (2007)
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2
H. Tinteren, O. Hoekstra, E. Smit, J. Bergh, A. Schreurs, R. Stallaert, P. Velthoven, E. Comans, Fred Diepenhorst, P. Verboom, J. Mourlk, P. Postmus, M. Boers, G. Teule (2002)
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trialThe Lancet, 359
U. Pastorino, M. Bellomi, C. Landoni, E. Fiori, P. Arnaldi, M. Picchio, G. Pelosi, P. Boyle, F. Fazio (2003)
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year resultsThe Lancet, 362
L. Heyneman, E. Patz (2002)
PET imaging in patients with bronchioloalveolar cell carcinoma.Lung cancer, 38 3
H. Vesselle, J. Grierson, M. Muzi, Jeffrey Pugsley, R. Schmidt, Peter Rabinowitz, L. Peterson, E. Vallières, D. Wood (2002)
In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 11
P. Marcus, E. Bergstralh, M. Zweig, A. Harris, K. Offord, R. Fontana (2006)
Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis.Journal of the National Cancer Institute, 98 11
C. Kutlu, U. Pastorino, M. Maisey, P. Goldstraw (1998)
Selective use of PET scan in the preoperative staging of NSCLC.Lung cancer, 21 3
Shanna Kim, M. Allen-Auerbach, J. Goldin, B. Fueger, M. Dahlbom, Matthew Brown, J. Czernin, C. Schiepers (2007)
Accuracy of PET/CT in characterization of solitary pulmonary lesions.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 48 2
L. Tanoue (2007)
CT Screening for Lung Cancer: Five-year Prospective ExperienceYearbook of Medicine, 2007
R. Peto, Alan Lopez, J. Boreham, M. Thun, C. Heath, R. Doll (1996)
Mortality from smoking worldwide.British medical bulletin, 52 1
S. Cheran, J. Herndon, E. Patz (2004)
Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.Lung cancer, 44 3
M. Gould, Courtney Maclean, W. Kuschner, C. Rydzak, D. Owens (2001)
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.JAMA, 285 7
Vinita Ahuja, R. Coleman, J. Herndon, E. Patz (1998)
The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinomaCancer, 83
D. Hellwig, D. Ukena, F. Paulsen, M. Bamberg, C. Kirsch (2001)
Metaanalyse zum Stellenwert der Positronen-Emissions-Tomographie mit F-18-Fluorodesoxyglukose (FDG-PET) bei Lungentumoren1 - Diskussionsbasis der deutschen Konsensus-Konferenz Onko-PET 2000 -Pneumologie, 55
A. Verdecchia, S. Francisci, H. Brenner, G. Gatta, A. Micheli, L. Mangone, I. Kunkler (2007)
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.The Lancet. Oncology, 8 9
M. Hickeson, M. Yun, A. Matthies, H. Zhuang, L. Adam, L. Lacorte, A. Alavi (2002)
Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 29
M. Vazquez, D. Carter, E. Brambilla, A. Gazdar, M. Noguchi, W. Travis, Yao Huang, Lijuan Zhang, R. Yip, D. Yankelevitz, C. Henschke (2009)
Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications.Lung cancer, 64 2
Rebecca Lindell, T. Hartman, S. Swensen, J. Jett, D. Midthun, M. Nathan, V. Lowe (2005)
Lung cancer screening experience: a retrospective review of PET in 22 non-small cell lung carcinomas detected on screening chest CT in a high-risk population.AJR. American journal of roentgenology, 185 1
U. Pastorino, G. Veronesi, C. Landoni, M. Leon, M. Picchio, P. Solli, F. Leo, L. Spaggiari, G. Pelosi, M. Bellomi, F. Fazio (2003)
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis.The Journal of thoracic and cardiovascular surgery, 126 6
S. Stroobants, J. Verschakelen, J. Vansteenkiste (2003)
Value of FDG-PET in the management of non-small cell lung cancer.European journal of radiology, 45 1
J. Vansteenkiste, B. Fischer, C. Dooms, J. Mortensen (2004)
Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review.The Lancet. Oncology, 5 9
J. Vansteenkiste (2003)
PET scan in the staging of non-small cell lung cancer.Lung cancer, 42 Suppl 1
(2009)
Accuracy of positron Journal of Thoracic Oncology
P. Bach, J. Jett, U. Pastorino, M. Tockman, S. Swensen, C. Begg (2007)
Computed tomography screening and lung cancer outcomes.JAMA, 297 9
J. Port, R. Andrade, M. Levin, R. Korst, Paul Lee, D. Becker, N. Altorki (2005)
Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less.The Journal of thoracic and cardiovascular surgery, 130 6
S. Swensen, J. Jett, T. Hartman, D. Midthun, S. Mandrekar, S. Hillman, A. Sykes, G. Aughenbaugh, A. Bungum, K. Allen (2005)
CT screening for lung cancer: five-year prospective experience.Radiology, 235 1
H. Nomori, Kenichi Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, K. Uno (2004)
Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.Lung cancer, 45 1
C. Henschke, D. Yankelevitz, D. Libby, M. Pasmantier, James Smith, O. Miettinen (2006)
Survival of patients with stage I lung cancer detected on CT screening.The New England journal of medicine, 355 17
U. Pastorino (2007)
Does screening for stage I lung cancer improve survival in a high-risk population?Nature Clinical Practice Oncology, 4
(2007)
Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer. A systematic review
Marcus (2006)
Extended Lung Cancer Incidence Follow-up in the Mayo Lung Project and OverdiagnosisJ Natl Cancer Inst, 98
ORIGINAL ARTICLE Fluorodeoxyglucose Uptake Measured by Positron Emission Tomography and Standardized Uptake Value Predicts Long-Term Survival of CT Screening Detected Lung Cancer in Heavy Smokers Ugo Pastorino, MD,* Claudio Landoni, MD,† Alfonso Marchiano`, MD,‡ Elisa Calabro`, MD,* Gabriella Sozzi, PhD,§ Rosalba Miceli, PhD, Maria Picchio, MD,† Luigi Mariani, PhD, Cristina Messa, MD,† and Ferruccio Fazio, MD† ung cancer causes over 1.3 millions annual deaths world- Background: Fluorodeoxyglucose-positron emission tomography Lwide. The overall survival of all detected lung cancers is (FDG-PET) has proven its value in the diagnosis of undetermined 2,3 15% in the United States and 10% in Europe. pulmonary lesions, lung cancer staging, and assessment of progno- In the last decade, nonrandomized trials on spiral com- sis. Purpose of this study is to clarify whether standardized uptake puted tomography (CT) screening have provided conflicting value (SUV) can predict clinical outcome of computed tomography results, where the higher proportion of CT detected stage I (CT) screening detected lung cancer. lung cancer and 90% estimated long-term survival, was Methods: We tested the predictive value of FDG-PET using SUV counterbalanced by a more than threefold excess of lung on long-term survival of 34 lung cancer patients, detected from 1035 cancer diagnosis
Journal of Thoracic Oncology – Wolters Kluwer Health
Published: Nov 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.